The beat-and-raise, combined with record margins and accelerating HSA account growth, signals strong operational momentum. Traders should watch for continued upside in custodial revenue as HSA cash reprices higher over the next 12-24 months. The raised guidance provides a clear catalyst for upward estimate revisions.
Price Chart
Executive Summary
HealthEquity reported Q2 FY2027 results with revenue of $350.7M (+8% YoY) and non-GAAP EPS of $1.24, a 3.9% beat vs. $1.19 consensus. The company raised full-year FY2027 guidance for revenue, net income, and Adjusted EBITDA, citing record HSA accounts (10.7M) and record Adjusted EBITDA margin of 48%. The beat-and-raise, driven by durable custodial revenue growth and operating leverage, is a clear positive for the stock.
Key Financial Metrics
Key Facts
- Revenue of $350.7M (+8% YoY) beat consensus of $349.2M.
- Non-GAAP EPS of $1.24 beat consensus of $1.19 by 4.2%.
- Adjusted EBITDA margin expanded to a record 48% from 46% a year ago.
- Total HSA Assets grew 14% YoY to $37.9B; HSA accounts grew 8% to 10.7M.
- FY2027 guidance raised: revenue $1.411B-$1.421B, Adj. EBITDA $628M-$636M, non-GAAP EPS $4.66-$4.73.
- Repurchased $108.1M of stock in Q2; $948.4M remaining on buyback authorization.
Financial Impact
Revenue beat by ~$1.5M; EPS beat by $0.05; FY guidance raised by ~$20M at midpoint
Risk Factors
- Interest rate sensitivity: HSA cash repricing schedule shows ~$2.3B at only 1.5% yield repricing in H2 FY2027, which could pressure custodial revenue if rates fall.
- Share buyback reduces float but also signals management sees limited better uses of capital; elevated buyback pace may not be sustainable.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001428336-26-000040 |
| Document: 0001428336-26-000040-index.html | 0001428336-26-000040 |
| Document: 0001428336-26-000040.txt | 0001428336-26-000040 |
| 8-K Data (Synthetic) | 0001428336-26-000040 |
Track record
20 reports on HQY
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 3, 202613d ago Press Release Neutral 2/10 Entry $108.84 Now $104.58 −3.91% settles Dec 3
- Oct 27, 202620d ago Institutional Cluster Neutral 3/10 Entry $100.88 Now $104.58 +3.67% settles Nov 24
- Oct 19, 202628d ago Insider Cluster Neutral 2/10 Entry $96.60 Now $104.58 +8.26% settles Nov 17
- Oct 9, 20265w ago 8-K Neutral 2/10 Entry $92.03 to $102.11 Now $104.58 +13.64% ▲ +10.95% +14.22% vs SPY
- Oct 9, 20265w ago SC 13G/A Neutral 3/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
- Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers